The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Angusta 25 microgram tablets

Norgine B.V.PA1336/010/001

Main Information

Trade NameAngusta 25 microgram tablets
Active SubstancesMisoprostol
Dosage FormTablet
Licence HolderNorgine B.V.
Licence NumberPA1336/010/001

Group Information

ATC CodeG02AD06 misoprostol


License statusAuthorised
Licence Issued30/10/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back